Providence Oncology and Hematology Care Eastside is a clinical research site located in Portland, Oregon, United States 97213.
Crixeo Health Trust Score: 63/100 (FAIR). This profile has not yet been claimed by the site owner.
Providence Oncology and Hematology Care Eastside has participated in 2 clinical trials.
Therapeutic areas: Any Tumor Type Eligible for Treatment With Talimogene Laherparepvec in Amgen or BioVEX-sponsored Clinical Trial, Melanoma, Non-Small Cell Lung Cancer.
Sponsors: Amgen, Genentech, Inc..
Trust Score: 63/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Providence Oncology and Hematology Care Eastside has a Crixeo Trust Score of 63/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Providence Oncology and Hematology Care Eastside has 2 clinical trials on record. Their work covers Any Tumor Type Eligible for Treatment With Talimogene Laherparepvec in Amgen or BioVEX-sponsored Clinical Trial, Melanoma, Non-Small Cell Lung Cancer.
Providence Oncology and Hematology Care Eastside has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.